An early RCT showed that atorvastatin 20 mg/d treated for 12 weeks was associated with significantly decreased circulating adiponectin in DM patients [18], while another study showed that treatment with atorvastatin 40 mg/d for 24 weeks increased adiponectin in patients with hyperlipidemia [25]. The gene discussed is ADIPOQ; the disease is diabetes mellitus.